Analysis of DNA mismatch repair genetic interactions in yeast and mouse
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
YU Faculty Profile
Abstract
The DNA mismatch repair (MMR) system is responsible for correcting base substitution and insertion-deletion mutations (IDLs) generated during erroneous replication in bacteria, yeast and mammals. MMR complexes also recognize damaged-base mispairs resulting from environmental exposure to DNA damaging agents. The loss of MMR causes a 'mutator' phenotype, resulting in the genome-wide accumulation of mutations, and is the underlying cause for Hereditary Nonpolyposis Colorectal Cancer / Lynch Syndrome (HNPCC/LS) and a significant proportion of sporadic colorectal cancer. The presence of alterations in length of 1-4 base nucleotide repeats (microsatellites), interspersed throughout the genome, is associated with MMR deficiency (microsatellite instability, MSI). Genes presenting "microsatellite-like" repeats in their coding regions are commonly mutated in MSIpositive colon cancers. One of the most frequently mutated genes in HNPCC/LS is the Transforming Growth Factor-beta receptor type II gene (TGFbeta-RII). Therefore the first project of my thesis was focused on testing whether TGF-betaR11 inactivation promotes colon tumorigenesis in a MMR deficient mouse model. I developed the first colon tumor model in a MMR deficient background. Moreover, this model resembles inflammatory-associated colon cancers in the context of MMR deficiency; hence, it offers a more faithful system to investigate critical oncogenic steps underlying inflammation-associated colon tumorigenesis and further to test the efficiency of chemotherapeutics treatments. MMR-deficient tumors also display resistance to DNA damaging agents and, as a consequence, are resistant to a variety of commonly used chemotherapeutic agents. Thus, the development of novel therapeutic strategies, targeting MMRdeficient cancer cells more efficiently, would be highly desirable. A promising new direction to identify potential targets for anticancer treatment is the harnessing of synthetic lethality. Here, we have identified conserved synthetic lethal / sick genetic interactions (GIs) for MMR factors between two distant yeast species, Schizosaccharomyces pombe (S. pombe) and Saccharomyces cerevisiae (S. cerevisiae). Specifically, we have identified a conserved negative genetic relationship between Msh2, a major MMR component mutated in colorectal cancer, and Senp6 protease, which regulates the deSUMOylation of a range of genome maintenance proteins. Our findings suggest that Senp6 is a promising new target for the treatment of MMR-deficient cancers.